Shailender Bhatia, MD

/content/dam/www/faculty-photos/B/shailender-bhatia/shailender-bhatia.jpg
Dr. Shailender Bhatia M.D.
FACULTY MEMBER

Shailender Bhatia, MD

Professor, Clinical Research Division, Fred Hutch

Professor
Clinical Research Division, Fred Hutch

Member, Pathogen-Associated Malignancies Integrated Research Center (PAM IRC)

Member
Pathogen-Associated Malignancies Integrated Research Center (PAM IRC)

Director, Melanoma and Renal Cancer Team, Fred Hutch

Director, Melanoma and Renal Cancer Team
Fred Hutch

Lyn and Daniel Lerner Endowed Chair for Merkel Cell Carcinoma, Fred Hutch

Lyn and Daniel Lerner Endowed Chair for Merkel Cell Carcinoma
Fred Hutch

Email:
Fax: 206.606.1314
Mail Stop: CE2-102

Dr. Shailender Bhatia aims to improve outcomes for people with kidney cancers and skin cancers, especially melanoma and Merkel cell carcinoma. He leads clinical trials of new immunotherapies and targeted, less-toxic therapies for patients with these diseases.

Other Appointments & Affiliations

Professor, Division of Hematology and Oncology, University of Washington

Professor, Division of Hematology and Oncology
University of Washington

Research Interests

Dr. Bhatia’s research efforts are mostly focused on clinical trials that aim at improving outcomes in skin cancers (especially Melanoma and Merkel cell carcinoma). He is especially interested in those novel therapeutic approaches that stimulate the immune system against cancer and those that target therapy to the tumors in order to spare unnecessary toxicity.